Avtal | $24,000,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
Certified by Founder
Lodge
Phialogics - The immune tolerance company
start up
Germany
- Frankfurt, Hesse
- 08/05/2023
- Pre-Seed
- $662,970
Our immune checkpoint activators protect patient’s organ tissue.
Unique approach :
- Potential for BEST-in-class super agonist against immune-mediated tissue damage
- High selectivity for active T-cells
- Proof of concept in relevant human in vitro models and mouse model of disease
- Industry Biotechnology Research
- Website https://www.phialogics.com/
- LinkedIn https://www.linkedin.com/company/phialogics/
Related People
Andreas ErnstFounder
Germany -
ND
Expert in protein engineering with a keen interest in drug development for the treatment of autoimmune diseases.
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)